Kunlun Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Kunlun Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Apr 21, 2021	EdiGene	$61.5M Series B	Andy Lin	3H Health Investment, Hongshan Capital Group (Sequoia Capital China), Huagai Capital, IDG Capital, Lilly Asia Ventures, Sherpa Healthcare Partners
Mar 31, 2021	Nice Tuan	$750.0M Other Equity	Alibaba, DST Global	Anatole Investment, CDH Investments, Jin Tao, D. E. Shaw group, Dragoneer Investment Group, Franchise Capital, GGV Capital, Jeneration Capital
Jan 19, 2021	Dian Xiaomi	$23.1M Series B	CDH Investments, GGV Capital	—
Nov 9, 2020	Inmagene Biopharmaceuticals	$21.0M Series B	—	SCVC
Nov 1, 2020	PingCAP	$270.0M Series D	5Y Capital, Pueo Keffer, Anatole Investment, Glenn Solomon, Jeneration Capital	Data Tech Fund, Granite Asia, Insight Partners, JLL Spark, Kleiner Perkins, Notable Capital, Y Combinator, John Kobs, Bertelsmann, Coatue, FutureX Capital, Matrix Partners China, Trustbridge Partners, Yunqi Partners
Oct 13, 2020	EdiGene	$66.9M Series B	Minchuan Wang	Green Pine Capital Partners, Hongshan Capital Group (Sequoia Capital China), Huagai Capital, IDG Capital, Lilly Asia Ventures
May 1, 2020	Kopi Kenangan	$210.0M Series B	Rohit Agarwal	305 Ventures, Arrive, B Capital Group, Bling Capital, Bond, Curie.Bio, Founders Fund, Goodwater Capital, Great Oaks Venture Capital, Khosla Ventures, Koch Fund, LGF, Operator Partners, Ribbit Capital, Sequoia Capital, Sierra Ventures, Streamlined Ventures, Tekton Ventures, Adrian Aoun, Samvit Ramadurgam, Sohail Prasad, Steve Chen, Alpha JWC Ventures, GIC, Horizons Ventures, Sofina, Verlinvest